BRCA1 Methylation in Breast Cancer Patients
Author Information
Author(s): Snell Cameron, Krypuy Michael, Wong Ee Ming, Loughrey Maurice B, Dobrovic Alexander
Primary Institution: Peter MacCallum Cancer Centre
Hypothesis
Inactivation of BRCA1 by promoter methylation could occur as a germline or an early somatic event that predisposes to breast cancer.
Conclusion
Low-level promoter methylation of BRCA1 occurs in normal tissues of some breast cancer patients and is associated with BRCA1-like breast cancer.
Supporting Evidence
- Three patients showed detectable BRCA1 methylation in their peripheral blood.
- One patient had 10% methylation of BRCA1 alleles in peripheral blood DNA.
- Two other patients had approximately 1% BRCA1 methylation detected.
Takeaway
Some people with breast cancer might have a gene called BRCA1 that is turned off by a process called methylation, even if they don't have the usual mutations in that gene.
Methodology
Methylation levels were tested using MethyLight, methylation-sensitive high resolution melting (MS-HRM), and digital MS-HRM assays.
Limitations
The study was limited to a small sample size and may not represent the broader population.
Participant Demographics
Participants were breast cancer patients from familial cancer families with BRCA1-like features.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website